Company intelligence / Profile preview

Hengba

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Hengba (Shanghai) Biotechnology is a high-tech enterprise focused on the research, development, and production of biological reagents and diagnostic kits. The company specializes in molecular diagnostics and high-throughput screening technologies, providing solutions for infectious disease detection and oncology research. Hengba operates primarily in the Chinese market, serving hospitals, research institutions, and clinical laboratories. Its business model encompasses the entire value chain from upstream reagent development to downstream diagnostic services.

Therapeutic areas: OncologyInfectious Diseases
Modalities: In vitro diagnosticsMolecular diagnostics
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Hengba.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hengba.

Explore the full profile